Objectives: The aim of this in vitro study was to assess the marginal adaptation of prefabricated Class I ceramic inlay restorations placed with various luting materials.
Methods: Forty-two standardized occlusal cavities were prepared in extracted human molars with diamond burs exactly corresponding to the dimensions of prefabricated glass ceramic inlays. The prepared teeth were randomly assigned to seven groups of six teeth each and restored using (1). the composite resin Tetric Ceram in increment technique [Group I] or (2). ceramic inlays (Cerana) luted with: the composite based materials Dual Cement [Gr. II] and Panavia 21 [Gr. III], the compomer material Dyract Cem [Gr. IV], Dyract Cem with additional use of Prime & Bond 2.1 [Gr. V], the silicophosphate cement Trans-Lit [Gr. VI], or the ethylcyanoacrylate Cyano-Veneer [Gr. VII]. Marginal adaptation was evaluated by SEM-analyses before and after thermal cycling (2500 cycles; 5-55 degrees C) and mechanical loading (100N; 500000 cycles) using replica models. Kruskal-Wallis H-test and Mann-Whitney U-test were used for statistical analyses.
Results: Group I (increment technique) as well as Groups II-V (inlay technique) revealed high percentages of perfect marginal adaptation in over 95% of the analyzed margins, both before and after thermo-mechanical loading. Statistical significant differences could not be detected within these groups. All inlays luted with silicophosphate cement (Group VI) and four of six inlays applied with Cyano-Veneer (Group VII) fractured under occlusal load.
Significance: A stable bonding to the enamel and to the ceramic inlay was achievable with the composite luting resins Dual Cement and Panavia 21 as well as with the compomer based luting material Dyract Cem but not with the use of the silicophosphate cement Trans-Lit or the ethylcyanoacrylate Cyano-Veneer.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0109-5641(02)00038-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Gut Microbiota and Osteoarthritis: From Pathogenesis to Novel Therapeutic Opportunities.
Am J Chin Med
January 2025
First Clinical Medical College, Yunnan University of Chinese Medicine, Kunming Yunnan 650500, P. R. China.
Osteoarthritis (OA) is the most common chronic degenerative joint disease, characterized by cartilage damage, synovial inflammation, subchondral bone sclerosis, marginal bone loss, and osteophyte development. Clinical manifestations include inflammatory joint pain, swelling, osteophytes, and limitation of motion. The pathogenesis of osteoarthritis has not yet been fully uncovered.
View Article and Find Full Text PDFOral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.
N Engl J Med
January 2025
From Médecins Sans Frontières (L.G., F.V.), Sorbonne Université, INSERM Unité 1135, Centre d'Immunologie et des Maladies Infectieuses (L.G.), Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux (L.G.), and Epicentre (M.G., E. Baudin), Paris, and Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier Université de Montpellier, Montpellier, Institut de Recherche pour le Développement, Montpellier, INSERM, Montpellier (M.B.) - all in France; Interactive Development and Research, Singapore (U.K.); McGill University, Epidemiology, Biostatistics, and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis (G.E.V., P.N., P.P.J.P.) and the Division of HIV, Infectious Diseases, and Global Medicine (G.E.V.), University of California at San Francisco, San Francisco; the National Scientific Center of Phthisiopulmonology (A.A., E. Berikova) and the Center of Phthisiopulmonology of Almaty Health Department (A.K.), Almaty, and the City Center of Phthisiopulmonology, Astana (Z.D.) - all in Kazakhstan; Médecins Sans Frontières (C.B., I.M.), the Medical Research Council Clinical Trials Unit at University College London (I.M.), and St. George's University of London Institute for Infection and Immunity (S.W.) - all in London; MedStar Health Research Institute, Washington, DC (M.C.); Médecins Sans Frontières, Mumbai (V. Chavan), the Indian Council of Medical Research Headquarters-New Delhi, New Delhi (S. Panda), and the Indian Council of Medical Research-National AIDS Research Institute, Pune (S. Patil) - all in India; the Centre for Infectious Disease Epidemiology and Research (V. Cox) and the Department of Medicine (H. McIlleron), University of Cape Town, and the Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine (S.W.) - both in Cape Town, South Africa; the Institute of Tropical Medicine, Antwerp, Belgium (B. C. J.); Médecins Sans Frontières, Geneva (G.F., N.L.); Médecins Sans Frontières, Yerevan, Armenia (O.K.); the National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia (N.K.); Partners In Health (M.K.) and Jhpiego Lesotho (L.O.) - both in Maseru; Socios En Salud Sucursal Peru (L.L., S.M.-T., J.R., E.S.-G., D.E.V.-V.), Hospital Nacional Sergio E. Bernales, Centro de Investigacion en Enfermedades Neumologicas (E.S.-G.), Hospital Nacional Dos de Mayo (E.T.), Universidad Nacional Mayor de San Marcos (E.T.), and Hospital Nacional Hipólito Unanue (D.E.V.-V.) - all in Lima; Global Health and Social Medicine, Harvard Medical School (L.L., K.J.S., M.L.R., C.D.M.), Partners In Health (L.L., K.J.S., M.L.R., C.D.M.), the Division of Global Health Equity, Brigham and Women's Hospital (K.J.S., M.L.R., C.D.M.), the Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, (L.T.), and Harvard T.H. Chan School of Public Health (L.T.) - all in Boston; and the Indus Hospital and Health Network, Karachi, Pakistan (H. Mushtaque, N.S.).
Background: For decades, poor treatment options and low-quality evidence plagued care for patients with rifampin-resistant tuberculosis. The advent of new drugs to treat tuberculosis and enhanced funding now permit randomized, controlled trials of shortened-duration, all-oral treatments for rifampin-resistant tuberculosis.
Methods: We conducted a phase 3, multinational, open-label, randomized, controlled noninferiority trial to compare standard therapy for treatment of fluoroquinolone-susceptible, rifampin-resistant tuberculosis with five 9-month oral regimens that included various combinations of bedaquiline (B), delamanid (D), linezolid (L), levofloxacin (Lfx) or moxifloxacin (M), clofazimine (C), and pyrazinamide (Z).
Integrated transcriptomics and metabolomics analyses provide new insights into cassava in response to nitrogen deficiency.
Front Plant Sci
January 2025
National Center of Technology Innovation for Saline-Alkali Tolerant Rice, College of Coastal Agricultural Sciences, Guangdong Ocean University, Zhanjiang, China.
Nitrogen deficiency is a key constraint on crop yield. Cassava, the world's sixth-largest food crop and a crucial source of feed and industrial materials, can thrive in marginal soils, yet its yield is still significantly affected by limited nitrogen availability. Investigating cassava's response mechanisms to nitrogen scarcity is therefore essential for advancing molecular breeding and identifying nitrogen-efficient varieties.
View Article and Find Full Text PDFMicro CT evaluation of marginal discrepancies of endocrown restored molars with different intrapulpal depths and materials of fabrication. (in-vitro study).
BMC Oral Health
January 2025
Faculty of dentistry, Ain Shams University, Cairo, Egypt.
Objective: The purpose of this study was to evaluate the effect of different preparation depths (0, 2 and 4 mm) of different restoration designs (classic endocrown design versus overlay design) on marginal adaptation of restorations fabricated of two different restorative materials (lithium disilicate and PEEK).
Materials And Methods: Sixty mandibular natural molars were collected as abutments for the restorations of this study, and grouped in three main groups of different cavity depths (0, 2 and 4). Each group was divided into two subgroups according to material of fabrication to (L) for lithium disilicate (IPS emax CAD, Ivoclar vivadent, Switzarland) and (P) for PEEK (Bio-hpp, Bredent, Germany).
Evidence-Based Surgical Guidelines for Treating Children With Rhabdomyosarcoma.
Pediatr Blood Cancer
January 2025
Department of Pediatric Surgery, Pediatric Oncology Institute - GRAACC - Federal University of São Paulo, São Paulo, Brazil.
Background: Surgery remains the cornerstone of treatment for rhabdomyosarcoma (RMS) in children. However, there is considerable variation in surgical management practices worldwide, highlighting the need for standardized Clinical Practice Guidelines (CPG).
Methods: The CPG development involved assembling a multidisciplinary group, prioritizing 10 key topic areas, conducting evidence searches, and synthesizing findings.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!